Examine a patient’s face mask prior to scanning as nose clips, headband staples, or other components can contain metal, potentially leading to facial burns during MRI scans.
When imaging a patient in an MRI during the COVID-19 pandemic, be sure he or she wears a face mask – but, also check to ensure their mask contains no metal or metal particles, warns the U.S. Food & Drug Administration (FDA).
In a safety communication issued Monday, the FDA alerted the imaging community that facial burns are possible in patients who wear metal-containing masks inside the MRI scanner. This advisory was prompted by a report to the agency of a patient experiencing burns consistent with the shape of a facial mask during a scan of the neck in a 3T MRI scanner.
Currently, facial masks are recommended to slow the spread of the SARS-CoV-2 virus, but those masks frequently contain metal nose clips or wires, as well as nanoparticles or antimicrobial particles that are coated with metal, typically silver or copper. Any metal content can get hot enough to burn a patient during an MRI.
Related Content: Keep an Eye Out for Magnetic Eyelashes
Patients are still advised to wear a mask during an MRI study, but to avoid these problems, the FDA recommended healthcare providers should screen all patients, checking and confirming that his or her face mask contains no metal before beginning the exam. If it is not possible to unequivocally determine that a mask contains no metal, patients should be given an alternative, non-metal containing mask.
Any confirmed or suspected burn event should be reported to the FDA, agency officials said, in an on-going attempt to improve MRI-related patient safety. Submit reports vis the FDA MedWatch Voluntary Reporting Form For questions, email the Division of Industry and Consumer Education at DICE@FDA.HHS.GOV or call 800-638-2041.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.